New research improves our understanding of cancer cell regulation

January 10, 2018, University of Liverpool

A team of cancer researchers from the University of Liverpool, has made an important contribution to our understanding of cancer cell regulation which could better inform future cancer treatments.

The research is funded by North West Cancer Research, which has ring-fenced £180,000 for the three year-long project which started in 2015.

Led by Professor Ian Prior at the University of Liverpool, in collaboration with researchers at AstraZeneca, the research focuses on a group of proteins found in the human body called kinases.

Their research measures how changes in kinase activity can influence the growth, development and regulation of . They measure kinase network rewiring that occurs in cancer patients so that they can identify new strategies for killing .

Their insights into this important family of proteins have been published in the highly regarded Cancer Research Journal and will provide a foundation for future research on the use of kinases in cancer treatments.

Some kinases are currently being successfully targeted in cancer therapies, which work by inhibiting kinases that trigger cancer cells to divide and grow. Yet there is still a lot to learn about kinases and the important role they could play within future cancer treatments.

The research has been published in the journal of Cancer Research.

Professor Prior, NWCR Chair of Molecular Oncology at the University of Liverpool explains: "Our research focused on getting under the microscope of cancer cell behaviour and understanding the effects that different proteins can have on this behaviour.

"Research into kinases, has been underway for many years now, but most attention has been focussed on only a few types, with relatively little known about the remaining types.

"Our publication in the Cancer Research Journal, highlights emerging and overlooked areas within research and discusses the successes and challenges associated with treating ."

North West Cancer Research secured £4million of funding for projects across Merseyside and the North West in 2017.

This includes £1million of funding to sustain research at the North West Cancer Research Centre at the University of Liverpool until 2021.

Alastair Richards, CEO North West Cancer Research said: "As a funder of cancer research, we are always pleased to hear when projects we have supported generate important breakthroughs in our understanding of cancer.

"We are committed to funding only the best quality research to help the fight against cancer here in the North West. But we cannot do this alone. We rely solely on public donations - which is why every penny we raise is so important.

"Without the help of our supporters and fundraisers we would not be able to continue to support the lifesaving research which is being carried out on our doorstep today."

Explore further: New kinase detection method helps identify targets for developing cancer drugs

More information: Leah J. Wilson et al, New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome, Cancer Research (2017). DOI: 10.1158/0008-5472.CAN-17-2291

Related Stories

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Versatile cancer drugs

December 1, 2017
Medications that block enzymes belonging to the kinase family are among the most effective pharmaceuticals for targeted cancer therapies. Scientists at the German Cancer Consortium (DKTK) at the Technical University of Munich ...

New role of protein kinases in embryo development and cancer

January 7, 2016
A group of protein kinases have been found to play an important role in embryo development and may even be a potential cancer drug target, says research led by Queen Mary University of London (QMUL) and the Francis Crick ...

New tool to probe cancer's molecular make-up

August 26, 2014
Scientists have shown how to better identify and measure vital molecules that control cell behaviour – paving the way for improved tools for diagnosis, prediction and monitoring of cancer.

Study identifies potential therapeutic targets for metastatic prostate cancer

December 2, 2015
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have pinpointed five specific enzymes called protein kinases that play a role when prostate cancer spreads to bone. The discovery ...

Map of substrate-kinase interactions may lead to more effective cancer drugs

March 27, 2012
(Medical Xpress) -- Later-stage cancers thrive by finding detours around roadblocks that cancer drugs put in their path, but a Purdue University biochemist is creating maps that will help drugmakers close more routes and ...

Recommended for you

High fruit and vegetable consumption may reduce risk of breast cancer, especially aggressive tumors

July 19, 2018
Women who eat a high amount of fruits and vegetables each day may have a lower risk of breast cancer, especially of aggressive tumors, than those who eat fewer fruits and vegetables, according to a new study led by researchers ...

Complementary medicine for cancer can decrease survival

July 19, 2018
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from ...

Overcoming resistance to a standard chemotherapy drug

July 19, 2018
Despite being studied for decades, the chemotherapy drug cisplatin is revealing new aspects of how it works. Researchers at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors ...

Study finds melanoma biomarkers predicting checkpoint blocker response

July 18, 2018
Scientists at Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) have identified biomarkers in melanoma that could help tailor immunotherapy treatments to maximize the benefits for patients while reducing the likelihood ...

Link found between bitter-taste sensitivity and cancer risk

July 18, 2018
High bitter-taste sensitivity is associated with a significantly increased risk of cancer in older British women, according to researchers who conducted a unique study of 5,500 women whose diet, lifestyle and health has been ...

Scientists discover a mechanism of drug resistance in breast and ovarian cancer

July 18, 2018
There is a highly sophisticated way to treat some breast and ovarian cancers—a class of drugs called PARP inhibitors, designed to exploit the very defects that make tumors with certain mutations especially deadly. Yet this ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.